Alina Vision secures investment from TVM Capital Healthcare

According to the announcement on January 16, TVM Capital Healthcare has invested in Alina Vision in a growth-buy out transaction involving The Fred Hollows Foundation from Australia and Rohto Pharmaceutical.

Alina Vision was founded by international development organisation The Fred Hollows Foundation in 2018. Over the past five years, The Foundation and Rohto Pharmaceutical, a top eye-care provider from Japan, have provided financial backing, eye-surgery training, and clinical support to Alina Vision to grow the organisation from inception to more than 80 employees across two eye hospitals.

Last year, Alina Vision completed over 2,800 cataract surgeries and intends to grow its network to a chain of hospitals across Vietnam with significantly increased capacity. Cataracts represent the most common cause of blindness in individuals aged 50 years and over in Vietnam, affecting mainly women. The demand for cataract surgeries is expected to rise significantly, surpassing the available service supply.

Ian Wishart, CEO of the Fred Hollows Foundation, said, "We are very pleased to have TVM Capital Healthcare on board to support us and the Alina Management team in scaling the business to help reduce avoidable blindness in Vietnam and the region. Alina Vision already invests significant resources in recruiting and training ophthalmologists, optometrists, and nurses with our and Rohto's help."

TVM Capital Healthcare is an emerging markets-focused healthcare private equity firm, with headquarters in Singapore and Dubai, and offices in Riyadh, Boston, Munich, and Ho Chi Minh City. The firm invests expansion and growth capital in healthcare companies with a focus on specialised and tech-enabled healthcare services and digital health solutions and platforms, as well as companies in pharmaceutical and medical-device manufacturing, and diagnostics.

Alina Vision operates hospitals in the underserved Vietnamese ophthalmology market, providing affordable and high-quality eye-care services for patients from all income levels to combat avoidable blindness.

Hoan My Medical Group dominates ACHSI Awards Two hospitals from Hoan My Medical Group were recognised for their innovative patient-centric projects at the Australian Council on Healthcare Standards International (ACHSI) Quality Improvement Award on December 7.

Imexpharm clinches top honours in corporate annual reporting Imexpharm, outstripping its 2023 financial targets, underscores its ascent with top honours in corporate governance, affirming its stature in Vietnam's pharmaceutical sector.

Solving Vietnam’s healthcare challenges In the face of a global shortage of radiologists and the consequential strain on healthcare professionals, GE HealthCare is making significant strides to alleviate burnout and elevate patient outcomes through the power of innovation and AI.